IGC Pharma, Inc. (IGC) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $0.31 (-4.07%)
Consensus Target
—
Upside
—
Analysts
3
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
IGC vs Sector & Market
| Metric | IGC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | — | +1708.8% | +16.4% |
| P/E Ratio | -5.58 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $1M | $1M | $1M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $-0.09 | $-0.09 | $-0.09 | 1 |
Frequently Asked Questions
What is the analyst consensus for IGC?
The consensus among 3 analysts covering IGC Pharma, Inc. (IGC) is Buy with an average price target of N/A.
How many analysts cover IGC?
3 analysts have issued ratings for IGC Pharma, Inc. in the past 12 months.
Is IGC a buy or sell right now?
Based on 3 analyst ratings, IGC has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for IGC?
Analysts estimate IGC will report EPS of $-0.09 for the period ending 2027-03-31, with revenue estimated at $1M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.